Press Room
  Date Title View
Nov 17, 2015
FOSTER CITY, Calif., Nov. 17, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at the 27th Annual Piper Jaffray Healthcare Conference at 10:30 am ET on Wednesday, December 2, 2015, at the New York Palace Hotel...
PDF
Nov 9, 2015
FOSTER CITY, Calif., Nov. 9, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended September 30, 2015. Revenues: In the third quarter of 2015, SciClone reported revenues of $42.9 million, compared to $34.3 million for the same period in 2014.  GAAP Diluted EPS: I...
PDF
Nov 3, 2015
FOSTER CITY, Calif., Nov. 3, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will participate in a panel discussion at the Boston Biotech Conferences (BBC) NY/NJ CEO conference on November 12th, at the Apella in New York City. The conference will foc...
PDF
Oct 26, 2015
FOSTER CITY, Calif., Oct. 26, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the third quarter 2015 on Monday, November 9, 2015. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that day. The call wil...
PDF
Sep 30, 2015
FOSTER CITY, Calif., Sept. 30, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Wilson W. Cheung, Chief Financial Officer, will present a corporate overview and business update at the 2015 Aegis Capital Growth Conference at 11:25 am PT on Friday, October 9, 2015, at The Encore at Wynn Las Vegas.   T...
PDF
Aug 27, 2015
FOSTER CITY, Calif., Aug. 27, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at two investor conferences on September 10, 2015, in New York City. 22nd Annual NewsMakers in the Biotech Industry: pr...
PDF
Aug 10, 2015
FOSTER CITY, Calif., Aug. 10, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended June 30, 2015.   Revenues: In the second quarter 2015, SciClone reported revenues of $37.9 million, compared to $32.5 million for the same period in 2014. GAAP Diluted EPS:...
PDF
Jul 23, 2015
FOSTER CITY, Calif., July 23, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the second quarter 2015 on Monday, August 10, 2015. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that day. The call wil...
PDF
May 27, 2015
FOSTER CITY, CA and GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 05/27/15 -- SciClone Pharmaceuticals (NASDAQ: SCLN), ("SciClone"), a U.S.-based, China-focused specialty pharmaceutical company, and Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma"), through an affiliate, today announced they have entered into a development and ...
PDF
May 26, 2015
FOSTER CITY, CA -- (Marketwired) -- 05/26/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Wilson W. Cheung, Chief Financial Officer, will present a corporate overview and business update at the Jefferies 2015 Global Healthcare Conference at 10:00 am ET on Wednesday, June 3, 2015, in New York City. To access...
PDF
FirstPrevious
3
...
NextLast